A szegedi Radiológiai Klinika és a NEK Szeged Kft. Képalkotó Centrum
a Magyar Radiológusok Társasága Ultrahang Szekciója közreműködésével
2006-ban ismét továbbképzési lehetőséget biztosít ultrahang témakörben!
A szokásos program és előadógárda újdonságokkal bővül!
Témák: fizikai-technikai alapok, hasi és kismedencei diagnosztika, vascularis ultrahang, lágyrészek-ízületek
Sok-sok esetelemzés, gyakorlat
Előadók: Humml Frigyes, Harkányi Zoltán, Morvay Zita, Makula Éva, Kovács Gabriella, Farbaky Zsófia, Kiss Éva, Riedl Erika
Szállás: kérés esetén kollégiumban ill. panziókban elhelyezést biztosítunk
Étkezés: a szünetekben frissítőt, délben szerény ebédet biztosítunk

Jelentkezési határidő: 2005. december 15.
Részvételi díj: részvételi díj: 25.000 Ft/fő

Why join?
New data from cardiovascular outcomes trials in diabetes have shown that some newer agents have proven CV benefits (e.g. GLP-1 receptor agonists and SGLT2 inhibitors). The compelling evidence has led to significant changes in treatment paradigms as reflected by the new ADA/EASD Consensus Report on the Management of Hyperglycaemia in Type 2 Diabetes.

This highly interactive and skills-based Masterclass will provide an opportunity to discuss the rationale and benefits of new clinical approaches and to share experiences with experts in the field of diabetes management.

Sessions will include:
• Strategies for individualizing therapy
• Applying new diabetes therapies with CV benefit in practice 
• Assessing cardiovascular risk 
• Obesity as a treatable condition 
• Instilling confidence in patients in using injectables 
• New formulations on the horizon

How do I join?
The masterclass is free of charge, travel and accommodation will be provided as appropriate.

To submit an application please visit https://integress.cvent.com/ASCENDMasterclass Places are limited.

Invitation

Why join?
New data from cardiovascular outcomes trials in diabetes have shown that some newer agents have proven CV benefits (e.g. GLP-1 receptor agonists and SGLT2 inhibitors). The compelling evidence has led to significant changes in treatment paradigms as reflected by the new ADA/EASD Consensus Report on the Management of Hyperglycaemia in Type 2 Diabetes.

This highly interactive and skills-based Masterclass will provide an opportunity to discuss the rationale and benefits of new clinical approaches and to share experiences with experts in the field of diabetes management.

Sessions will include:
• Strategies for individualizing therapy
• Applying new diabetes therapies with CV benefit in practice 
• Assessing cardiovascular risk 
• Obesity as a treatable condition 
• Instilling confidence in patients in using injectables 
• New formulations on the horizon

How do I join?
The masterclass is free of charge, travel and accommodation will be provided as appropriate.

To submit an application please visit https://integress.cvent.com/ASCENDMasterclass Places are limited.

Invitation